Summary

The Asia-Pacific corneal transplant market is expected to reach USD 123.59 million by 2031 from USD 71.26 million in 2023, growing at a CAGR of 7.2% in the forecast period of 2024 to 2031.
Market Segmentation:
Asia-Pacific Corneal Transplant Market, By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artifical Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others), Countries (China, India, Japan, Australia, South Korea, Singapore, Philippines, Malaysia, Indonesia, Thailand and Rest of Asia-Pacific) - Industry Trends and Forecast to 2031

Overview of Asia-Pacific Corneal Transplant Market Dynamics:

Driver

• Increasing prevalence of eye diseases
Restrain

• High cost associated with corneal transplant surgery

Opportunity

• Rise in healthcare infrastructure

Market Players:

The key market players operating in the Asia-Pacific corneal transplant market are listed below:

• ZEISS Group (Carl Zeiss Meditec AG.)
• Alcon
• Ziemer Ophthalmic Systems AG
• RUMEX International Co.
• AJL Ophthalmic S.A.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF THE ASIA-PACIFIC CORNEAL IMPLANTS MARKET 20
1.4 CURRENCY AND PRICING 22
1.5 LIMITATIONS 22
1.6 MARKETS COVERED 22
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 DBMR TRIPOD DATA VALIDATION MODEL 28
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.6 MULTIVARIATE MODELLING 32
2.7 MARKET END USER COVERAGE GRID 33
2.8 DBMR MARKET POSITION GRID 34
2.9 VENDOR SHARE ANALYSIS 35
2.10 SECONDARY SOURCES 36
2.11 ASSUMPTIONS 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 43
4.1 PESTLE ANALYSIS 44
4.2 PORTERS FIVE FORCES ANALYSIS 45
5 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: REGULATIONS 46
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION 46
5.2 NORTH AMERICA REGULATORY SCENARIO 50
5.3 EUROPE REGULATORY SCENARIO 55
5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO 57
5.5 SOUTH AMERICA REGULATORY SCENARIO 60
6 CUSTOMIZATION 65
7 MARKET OVERVIEW 72
7.1 DRIVERS 74
7.1.1 INCREASING PREVALENCE OF EYE DISEASES 74
7.1.2 RISING GERIATRIC POPULATION 75
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS 76
7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT 77
7.2 RESTRAINTS 78
7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY 78
7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT 79
7.3 OPPORTUNITIES 80
7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE 80
7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION 80
7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS 81
7.4 CHALLENGES 83
7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS 83
7.4.2 LIMITED AWARENESS AND TRAINING 83
8 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY TYPE 85
8.1 OVERVIEW 86
8.2 HUMAN CORNEA 89
8.3 SYNTHETIC 90
9 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE 91
9.1 OVERVIEW 92
9.2 ENDOTHELIAL KERATOPLASTY 95
9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK) 96
9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK) 96
9.3 PENETRATING KERATOPLASTY 96
9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK) 97
9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK) 97
9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK) 97
9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT 98
9.6 ARTIFICIAL CORNEA TRANSPLANT 98
9.7 OTHERS 99
10 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY DONOR TYPE 100
10.1 OVERVIEW 101
10.2 ALLOGRAFT 104
10.3 AUTOGRAFT 105
11 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY INDICATION 106
11.1 OVERVIEW 107
11.2 FUCH'S ENDOTHELIAL DYSTROPHY 110
11.3 INFECTIOUS KERATITIS 111
11.4 BULLOUS KERATOPATHY 112
11.5 KERATOCONUS 112
11.6 REGRAFT PROCEDURES 113
11.7 CORNEAL SCARRING 113
11.8 CORNEAL ULCERS 114
11.9 OTHERS 114
12 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE 115
12.1 OVERVIEW 116
12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR) 119
12.2.1 DEEP LAMELLAR GRAFTS 120
12.2.2 SUPERFICIAL LAMELLAR GRAFTS 120
12.3 FULL THICKNESS GRAFTS (PENETRATING) 120
13 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE 121
13.1 OVERVIEW 122
13.2 CONVENTIONAL SURGERY 125
13.3 LASER-ASSISTED SURGERY 126
14 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GENDER 127
14.1 OVERVIEW 128
14.2 FEMALE 131
14.3 MALE 132
15 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY AGE GROUP 133
15.1 OVERVIEW 134
15.2 GERIATRIC 137
15.3 ADULT 138
15.4 PEDIATRIC 139
16 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY END USER 140
16.1 OVERVIEW 141
16.2 HOSPITALS 144
16.3 EYE CLINICS 145
16.4 AMBULATORY SURGICAL CENTERS 145
16.5 ACADEMIC & RESEARCH INSTITUTES 146
16.6 OTHERS 146
17 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY REGION 147
17.1 ASIA-PACIFIC 150
17.1.1 CHINA 155
17.1.2 INDIA 159
17.1.3 JAPAN 163
17.1.4 AUSTRALIA 167
17.1.5 SOUTH KOREA 171
17.1.6 SINGAPORE 175
17.1.7 PHILIPPINES 179
17.1.8 MALAYSIA 183
17.1.9 INDONESIA 187
17.1.10 THAILAND 191
17.1.11 REST OF ASIA-PACIFIC 195
18 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE 196
18.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
19 SWOT ANALYSIS 197
20 COMPANY PROFILES 198
20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.) 198
20.1.1 COMPANY SNAPSHOT 198
20.1.2 REVENUE ANALYSIS 198
20.1.3 COMPANY SHARE ANALYSIS 199
20.1.4 PRODUCT PORTFOLIO 199
20.1.5 RECENT DEVELOPMENTS 200
20.2 ALCON 201
20.2.1 COMPANY SNAPSHOT 201
20.2.2 REVENUE ANALYSIS 202
20.2.3 COMPANY SHARE ANALYSIS 202
20.2.4 PRODUCT PORTFOLIO 203
20.2.5 RECENT DEVELOPMENT 203
20.3 CORNEAGEN 204
20.3.1 COMPANY SNAPSHOT 204
20.3.2 COMPANY SHARE ANALYSIS 204
20.3.3 PRODUCT PORTFOLIO 205
20.3.4 RECENT DEVELOPMENT 206
20.4 ZIEMER OPHTHALMIC SYSTEMS AG 207
20.4.1 COMPANY SNAPSHOT 207
20.4.2 COMPANY SHARE ANALYSIS 207
20.4.3 PRODUCT PORTFOLIO 208
20.4.4 RECENT DEVELOPMENT 208
20.5 RUMEX INTERNATIONAL CO. 209
20.5.1 COMPANY SNAPSHOT 209
20.5.2 COMPANY SHARE ANALYSIS 209
20.5.3 PRODUCT PORTFOLIO 210
20.5.4 RECENT DEVELOPMENT 211
20.6 AJL OPHTHALMIC S.A. 212
20.6.1 COMPANY SNAPSHOT 212
20.6.2 PRODUCT PORTFOLIO 212
20.6.3 RECENT DEVELOPMENT 212
20.7 CORNEAT VISION 213
20.7.1 COMPANY SNAPSHOT 213
20.7.2 PRODUCT PORTFOLIO 213
20.7.3 RECENT DEVELOPMENT 213
20.8 FLORIDA LIONS EYE BANK 214
20.8.1 COMPANY SNAPSHOT 214
20.8.2 PRODUCT PORTFOLIO 214
20.8.3 RECENT DEVELOPMENT 214
20.9 KERAMED, INC. 215
20.9.1 COMPANY SNAPSHOT 215
20.9.2 PRODUCT PORTFOLIO 215
20.9.3 RECENT DEVELOPMENT 215
20.10 MASSACHUSETTS EYE AND EAR 216
20.10.1 COMPANY SNAPSHOT 216
20.10.2 PRODUCT PORTFOLIO 216
20.10.3 RECENT DEVELOPMENT 217
20.11 OCL VISION 218
20.11.1 COMPANY SNAPSHOT 218
20.11.2 SERVICE PORTFOLIO 218
20.11.3 RECENT DEVELOPMENT 218
20.12 OVATION INTERNATIONAL 219
20.12.1 COMPANY SNAPSHOT 219
20.12.2 PRODUCT PORTFOLIO 219
20.12.3 RECENT DEVELOPMENT 219
20.13 SAN DIEGO EYE BANK 220
20.13.1 COMPANY SNAPSHOT 220
20.13.2 SERVICE PORTFOLIO 220
20.13.3 RECENT DEVELOPMENT 220
21 QUESTIONNAIRE 221
22 RELATED REPORTS 225